MENU
+Compare
NVCT
Stock ticker: NASDAQ
AS OF
May 14, 04:59 PM (EDT)
Price
$9.27
Change
+$0.84 (+9.96%)
Capitalization
199M

NVCT Nuvectis Pharma Forecast, Technical & Fundamental Analysis

Nuvectis Pharma Inc is a biopharmaceutical company... Show more

NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NVCT with price predictions
May 13, 2025

NVCT in -9.06% downward trend, declining for three consecutive days on May 12, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NVCT declined for three days, in of 194 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVCT as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVCT turned negative on May 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 29 similar instances when the indicator turned negative. In of the 29 cases the stock turned lower in the days that followed. This puts the odds of success at .

NVCT moved below its 50-day moving average on May 12, 2025 date and that indicates a change from an upward trend to a downward trend.

NVCT broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NVCT advanced for three days, in of 191 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 92 cases where NVCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.497) is normal, around the industry mean (14.420). P/E Ratio (0.000) is within average values for comparable stocks, (65.047). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.146). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.920).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NVCT is expected to report earnings to fall 191.11% to -24 cents per share on August 06

Nuvectis Pharma NVCT Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.53
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.26
The last earnings report on May 06 showed earnings per share of 27 cents, beating the estimate of -25 cents. With 61.17K shares outstanding, the current market capitalization sits at 199.00M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Bridge Plaza
Phone
+1 201 614-3150
Employees
13
Web
https://www.nuvectis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPXUX15.410.13
+0.82%
WisdomTree 500 Digital N/A
GIEYX15.56N/A
N/A
GuideStone Funds International Eq Instl
FSDIX17.12N/A
N/A
Fidelity Strategic Dividend & Income
GSVPX16.01N/A
N/A
Goldman Sachs Small/Mid Cap Value P
TIHIX13.16N/A
N/A
Transamerica International Stock I2

NVCT and Stocks

Correlation & Price change

A.I.dvisor tells us that NVCT and DARE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and DARE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+0.54%
DARE - NVCT
30%
Poorly correlated
+0.35%
SGMT - NVCT
29%
Poorly correlated
-3.93%
FTRE - NVCT
28%
Poorly correlated
-3.66%
CELU - NVCT
27%
Poorly correlated
+23.03%
PDSB - NVCT
27%
Poorly correlated
-1.55%
More